M1 Kliniken AG (ETR:M12)
Germany · Delayed Price · Currency is EUR 20.95
+0.55 (2.70%)
Sep 16, 2026, 4:42 PM CET
M1 Kliniken AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 379 | 353 | 308 | 205 | 168 | 139 | |
Market Cap Growth | 45.09% | 14.46% | 50.16% | 21.86% | 20.80% | -23.23% |
Enterprise Value | 350 | 367 | 346 | 246 | 182 | 157 |
Last Close Price | 20.40 | 17.77 | 14.99 | 9.82 | 7.95 | 6.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.83 | 15.93 | 19.23 | 19.97 | 38.99 | 15.65 |
Forward PE | - | 20.21 | 18.92 | 25.17 | 29.71 | 17.86 |
PS Ratio | 1.46 | 0.97 | 0.91 | 0.65 | 0.59 | 0.44 |
PB Ratio | 2.49 | 2.35 | 2.30 | 1.43 | 1.18 | 1.00 |
P/TBV Ratio | 6.43 | 11.64 | 16.06 | 7.76 | 4.65 | 1.74 |
P/FCF Ratio | 13.97 | 9.32 | 10.34 | 27.89 | 8.59 | 9.51 |
P/OCF Ratio | 13.86 | 9.29 | 10.08 | 26.27 | 8.11 | 8.88 |
PEG Ratio | - | 0.58 | 0.49 | 0.49 | 8.49 | 0.59 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.35 | 1.01 | 1.02 | 0.78 | 0.64 | 0.50 |
EV/EBITDA Ratio | 9.66 | 10.39 | 12.74 | 14.52 | 17.17 | 10.87 |
EV/EBIT Ratio | 10.99 | 10.75 | 13.43 | 15.98 | 20.34 | 12.92 |
EV/FCF Ratio | 12.92 | 9.71 | 11.61 | 33.40 | 9.28 | 10.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.07 | 0.16 | 0.11 | 0.13 | 0.22 |
Debt / EBITDA Ratio | 0.11 | 0.26 | 0.68 | 0.78 | 1.30 | 1.73 |
Debt / FCF Ratio | 0.15 | 0.27 | 0.71 | 2.20 | 0.98 | 2.09 |
Net Debt / Equity Ratio | -0.37 | -0.21 | 0.00 | -0.05 | -0.20 | -0.13 |
Net Debt / EBITDA Ratio | -1.73 | -0.90 | -0.02 | -0.39 | -2.67 | -1.28 |
Net Debt / FCF Ratio | -2.08 | -0.84 | -0.02 | -0.89 | -1.44 | -1.26 |
Asset Turnover | 1.36 | 1.93 | 1.69 | 1.54 | 1.44 | 1.63 |
Inventory Turnover | 9.16 | 9.08 | 7.19 | 7.77 | 8.09 | 7.27 |
Quick Ratio | 3.26 | 1.60 | 1.02 | 1.01 | 2.00 | 1.56 |
Current Ratio | 5.48 | 2.82 | 1.91 | 1.90 | 2.86 | 2.54 |
Return on Equity (ROE) | 15.29% | 16.96% | 12.83% | 8.15% | 5.00% | 8.53% |
Return on Assets (ROA) | 10.46% | 11.33% | 8.03% | 4.69% | 2.83% | 3.92% |
Return on Invested Capital (ROIC) | 22.91% | 19.21% | 12.89% | 8.67% | 5.23% | 7.57% |
Return on Capital Employed (ROCE) | 20.20% | 21.70% | 17.90% | 9.90% | 5.60% | 7.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.34% | 6.28% | 5.20% | 5.01% | 2.56% | 6.39% |
FCF Yield | 7.16% | 10.73% | 9.67% | 3.58% | 11.65% | 10.52% |
Dividend Yield | 6.32% | 6.75% | 3.33% | 5.09% | - | - |
Payout Ratio | 46.02% | 42.06% | 58.12% | 19.28% | 42.24% | 18.62% |
Buyback Yield / Dilution | -1.30% | - | 2.98% | -4.43% | 1.43% | 0.02% |
Total Shareholder Return | 5.02% | 6.75% | 6.32% | 0.66% | 1.43% | 0.02% |